Russell Cohen, MD, Discusses Medication Adherence in Inflammatory Bowel Disease
Russell Cohen, MD, says medication adherence is an important issue for inflammatory bowel disease (IBD), because patients must stay on medications long term. Dr Cohen comments, "IBD is a chronic relapsing condition, you don't just stop your medicines." There have been many breakthroughs in medication adherence for managing IBD. For instance, Dr Cohen says once-a-day dosing ensures patients don't fall behind in taking their prescribed medications.
This video was taken on May 2, 2013, at the NAMCP Spring Managed Care Forum in Orlando, FL.
The "Know Your Tumor" initiative of the Pancreatic Cancer Action network refers newly diagnosed patients to Perthera, which provides a unique service to ensure timely tissue collection, molecular diagnostic testing, and a report with recommendations for the oncologist.
Knowledge is power, as was the case with a doctoral student at MIT whose keen interest in his own medical data resulted in the diagnosis and excision of a brain tumor. But are all health systems ready to share patients' data with them?
To mark its 20th year of publication, The American Journal of Managed Care has invited guest contributors to comment on the state of healthcare from their perspective. This month, Karen Ignagni, MBA, president and CEO of America’s Health Insurance Plans and consistently rated as one of healthcare’s most important voices, writes how health plans are supporting value-based care and promoting consumer choice.